Oncology
2290 articles · 70 journals
Journals in this subcategory (70)
- EJC Skin Cancer · Elsevier (91)
- Biochimica et Biophysica Acta: Reviews on Cancer · Elsevier (90)
- Blood Neoplasia · Elsevier (90)
- The Lancet Oncology · Elsevier (89)
- Cancer Treatment and Research Communications · Elsevier (85)
- European Journal of Surgical Oncology · Elsevier (85)
- Journal of Thoracic Oncology · Elsevier (83)
- Brachytherapy · Elsevier (81)
- Cancer Epidemiology · Elsevier (81)
- International Journal of Gynecological Cancer · Elsevier (80)
- Asia-Pacific Journal of Clinical Oncology · Wiley (72)
- Lung Cancer · Elsevier (69)
- European Journal of Cancer · Elsevier (68)
- Critical Reviews in Oncology/Hematology · Elsevier (67)
- Leukemia Research Reports · Elsevier (66)
- Surgical Oncology Clinics of North America · Elsevier (66)
- Urologic Oncology: Seminars and Original Investigations · Elsevier (64)
- Gynecologic Oncology Reports · Elsevier (62)
- Bulletin du Cancer · Elsevier (59)
- Translational Oncology · Elsevier (58)
- Blood Reviews · Elsevier (54)
- Journal of the National Cancer Center · Elsevier (54)
- The Journal of Liquid Biopsy · Elsevier (53)
- Leukemia Research · Elsevier (52)
- Cancer Letters · Elsevier (51)
- Trends in Cancer · Elsevier (49)
- JACC: CardioOncology · Elsevier (46)
- Surgical Oncology Insight · Elsevier (43)
- Clinical Breast Cancer · Elsevier (39)
- ESMO Open · Elsevier (38)
- Cancer Pathogenesis and Therapy · Elsevier (37)
- Clinical Lung Cancer · Elsevier (33)
- Current Problems in Cancer: Case Reports · Elsevier (30)
- Journal of Geriatric Oncology · Elsevier (30)
- Journal of Bone Oncology · Elsevier (29)
- Intelligent Oncology · Elsevier (20)
- Precision Radiation Oncology · Wiley (20)
- Current Problems in Cancer · Elsevier (17)
- Immuno-Oncology and Technology · Elsevier (16)
- Best Practice & Research Clinical Haematology · Elsevier (12)
- npj Precision Oncology · Springer Nature (12)
- MedComm - Oncology · Wiley (10)
- European Journal of Cancer: Supplement · Elsevier (9)
- Nature Reviews Cancer · Springer Nature (9)
- British Journal of Cancer · Springer Nature (8)
- Nature Reviews Clinical Oncology · Springer Nature (8)
- Cancer Cytopathology · Wiley (5)
- BMC Cancer · Springer Nature (0)
- Breast Cancer Research · Springer Nature (0)
- Breast Cancer Research and Treatment · Springer Nature (0)
- Cancer Cell International · Springer Nature (0)
- Cancer Chemotherapy and Pharmacology · Springer Nature (0)
- Cancer and Metastasis Reviews · Springer Nature (0)
- Cardio-Oncology · Springer Nature (0)
- Cellular Oncology · Springer Nature (0)
- Clinical and Translational Oncology · Springer Nature (0)
- Current Breast Cancer Reports · Springer Nature (0)
- Current Hematologic Malignancy Reports · Springer Nature (0)
- Current Oncology Reports · Springer Nature (0)
- Immuno-Oncology · Springer Nature (0)
- Indian Journal of Gynecologic Oncology · Springer Nature (0)
- Indian Journal of Surgical Oncology · Springer Nature (0)
- Journal of Cancer Research and Clinical Oncology · Springer Nature (0)
- Journal of Gastrointestinal Cancer · Springer Nature (0)
- Journal of Mammary Gland Biology and Neoplasia · Springer Nature (0)
- Journal of the Egyptian National Cancer Institute · Springer Nature (0)
- Molecular Cancer · Springer Nature (0)
- Oncology and Therapy · Springer Nature (0)
- Strahlentherapie und Onkologie · Springer Nature (0)
- best practice onkologie · Springer Nature (0)
- Latent Profile Analysis of Reproductive Concerns in Thyroid Cancer Survivors: Implications for Stratified Fertility Preservation Interventions
-
Postoperative timing effects on AI-based resection-cavity segmentation in glioma: multi-site evaluation and relevance assessment
npj Precision Oncology, Published online: 19 November 2026; doi:10.1038/s41698-026-01786-3 Postoperative timing effects on AI-based resection-cavity segmentation in glioma: multi-site evaluation and relevance assessment
-
Targeting SMYD3 in cancer-associated fibroblasts relieves immune suppression and improves anti-PD-L1 response in HPV-negative HNSCC
npj Precision Oncology, Published online: 19 November 2026; doi:10.1038/s41698-026-01779-2 Targeting SMYD3 in cancer-associated fibroblasts relieves immune suppression and improves anti-PD-L1 response in HPV-negative HNSCC
-
Flexible strategy for purine supply in tumours
Nature Reviews Cancer, Published online: 19 November 2026; doi:10.1038/s41568-026-01001-2 In this Journal Club, Chien-Han Kao and Ruey-Hwa Chen discuss a study showing that tumours use both de novo purine biosynthesis and purine salvage...
- Update on the impact of volume and cellularity on serous fluids: Nondiagnostic definitions and criteria for the upcoming International System v2
- Repeat FNA for risk stratification of atypia of undetermined significance in thyroid nodules: A population‐based cohort without molecular testing
- Radiotherapy combined with immunomodulator therapy for monomorphic epitheliotropic intestinal T‐cell lymphoma (MEITL) after surgery and chemotherapy: a case report
-
A feasibility study for resolving cellular populations in precision cancer medicine by integrating single-cell multiomics
npj Precision Oncology, Published online: 18 November 2026; doi:10.1038/s41698-026-01789-0 A feasibility study for resolving cellular populations in precision cancer medicine by integrating single-cell multiomics
-
Accelerating access to precision oncology trials: risk-benefit framework for local biomarker tests for patient enrollment
npj Precision Oncology, Published online: 18 November 2026; doi:10.1038/s41698-026-01765-8 Accelerating access to precision oncology trials: risk-benefit framework for local biomarker tests for patient enrollment
-
From the ESMO Congress 2026
Nature Reviews Clinical Oncology, Published online: 18 November 2026; doi:10.1038/s41571-026-01234-y From the ESMO Congress 2026
-
Cancer vaccines in the era of immunotherapy: from antigen delivery to immune ecosystem engineering
Nature Reviews Clinical Oncology, Published online: 17 November 2026; doi:10.1038/s41571-026-01224-0 Therapeutic cancer vaccines reliably induce antitumour immune responses but evidence of translation into clinical benefit has largely...
-
Global landscape of early-onset breast cancer: from understanding risk to precision prevention and cancer interception
Nature Reviews Clinical Oncology, Published online: 17 November 2026; doi:10.1038/s41571-026-01222-2 The rising incidence and persistent disparities that characterize early-onset breast cancers (those diagnosed before 50 years of age)...
-
LDHA is orchestrated deubiquitination by USP39 confers tolerance of hepatocellular carcinoma to immune checkpoint inhibitors
npj Precision Oncology, Published online: 15 November 2026; doi:10.1038/s41698-026-01803-5 LDHA is orchestrated deubiquitination by USP39 confers tolerance of hepatocellular carcinoma to immune checkpoint inhibitors
- Utilizing Afirma GRID scores to further stratify genomic sequencing classifier–suspicious thyroid nodules
- Risk Factor Profiles May Differ Between Younger‐Onset and Late‐Onset Colorectal Cancer: An Exploratory Analysis of Individual and Cumulative Risk Factors Among the Prostate, Lung, Colorectal and Ovarian Cohort
-
HGS-BioAbductor: hypergraph-based explainable survival modelling and LLM-based biological hypothesis abduction
npj Precision Oncology, Published online: 14 November 2026; doi:10.1038/s41698-026-01764-9 HGS-BioAbductor: hypergraph-based explainable survival modelling and LLM-based biological hypothesis abduction
-
Intratumoral bacterial LPS drives metabolic reprogramming to promote nasopharyngeal carcinoma progression
npj Precision Oncology, Published online: 14 November 2026; doi:10.1038/s41698-026-01791-6 Intratumoral bacterial LPS drives metabolic reprogramming to promote nasopharyngeal carcinoma progression
- Targeting Therapy‐Induced Vulnerabilities in Colorectal Cancer
-
AI-based prediction of actionable genomic alterations from H&E-stained slides
npj Precision Oncology, Published online: 13 November 2026; doi:10.1038/s41698-026-01772-9 AI-based prediction of actionable genomic alterations from H&E-stained slides
-
The antioxidant addiction of cancer
Nature Reviews Cancer, Published online: 13 November 2026; doi:10.1038/s41568-026-00997-x Antioxidant pathways support tumour growth, metastasis and therapy resistance while protecting cancer cells from ferroptosis. In this Perspective,...
- Transarterial Chemoembolization and Chemo‐Immunoembolization in Locally Advanced Rectal Cancer: An Updated Systematic Review
-
Telomere maintaining germline and somatic variants in thyroid cancer and melanoma
npj Precision Oncology, Published online: 12 November 2026; doi:10.1038/s41698-026-01758-7 Telomere maintaining germline and somatic variants in thyroid cancer and melanoma
-
Beyond the tumour: circulating extracellular matrix fragments as next-generation cancer biomarkers
Nature Reviews Cancer, Published online: 12 November 2026; doi:10.1038/s41568-026-00991-3 Through the action of proteases, the tumour-derived extracellular matrix (ECM) generates circulating ECM fragments that reflect dynamic tumour...
- Reframing Natural Killer Cell Biology for Cancer: From Cytotoxic Potential to Context‐Matched Immune States
-
Toxicity, health-related quality of life and sexuality after molecular profile-based adjuvant treatment in high-intermediate risk endometrial cancer, PORTEC-4a
British Journal of Cancer, Published online: 11 November 2026; doi:10.1038/s41416-026-03642-4 Toxicity, health-related quality of life and sexuality after molecular profile-based adjuvant treatment in high-intermediate risk endometrial...
- Implementation of a rapid onsite molecular adequacy protocol for endoscopic ultrasound–guided sampling of pancreatic ductal adenocarcinoma
- Issue Information
-
T cell redirection in high-risk smouldering multiple myeloma: can deep responses prevent progression to multiple myeloma?
Nature Reviews Clinical Oncology, Published online: 10 November 2026; doi:10.1038/s41571-026-01230-2 The randomized phase II ImmunoPRISM trial has shown encouraging efficacy of the B cell maturation antigen-targeted bispecific T cell...
-
3D models to capture and perturb tumour heterogeneity in vitro
Nature Reviews Cancer, Published online: 10 November 2026; doi:10.1038/s41568-026-00993-1 Tumour heterogeneity drives disease progression yet remains difficult to capture in experimental systems. In this Review, Fomina and McGuigan...
-
Divarasib outperforms first-generation KRAS-G12C inhibitors in NSCLC
Nature Reviews Clinical Oncology, Published online: 09 November 2026; doi:10.1038/s41571-026-01233-z Divarasib outperforms first-generation KRAS-G12C inhibitors in NSCLC